Donepezil

ArtNr	HY-14566-10mg
Hersteller	MedChem Express
CAS-Nr.	120014-06-4
Menge	10 mg
Quantity options	100 mg 10 mM/1 mL 10 mg 50 mg 5 mg
Kategorie	Oncology Neuroscience Molecular Targets for Neuroscience Aging & Neurological Disorders Inhibitors & Compound Libraries Small Molecules By Organ Brain Cancer Nervous System Cancer
Typ	Inhibitors
Specific against	other
Purity	99.91
Citations	[1]Ogura, H., et al., Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro. Methods Find Exp Clin Pharmacol, 2000. 22(8): p. 609-13.\|[2]Snape, M.F., et al., A comparative study in rats of the in vitro and in vivo pharmacology of the acetylcholinesterase inhibitors tacrine, donepezil and NXX-066. Neuropharmacology, 1999. 38(1): p. 181-93.\|[3]Huang, Z.H., et al., Donepezil protects endothelial cells against hydrogen peroxide-induced cell injury. CNS Neurosci Ther, 2012. 18(2): p. 185-7. bioRxiv. 2024 Dec 23:2024.12.22.629999.\|Chem Biodivers. 2025 Jan 7:e202402771.\|Comput Struct Biotec. 2023 Feb 24.\|Eur J Med Chem. 2023 Dec 21, 116071.\|Foods. 2022, 11(14), 2095.\|J Ethnopharmacol. 2024 Nov 9;338(Pt 1):119017.\|J Ethnopharmacol. 2025 Mar 10:119619.\|Journal of Pharmaceutical Investigation. 2021 Mar 31.\|Phytomedicine. 2024 Jun 4:131:155802.\|Alzheimers Res Ther. 2025 Feb 14;17(1):43.\|Clin Transl Med. 2021 May 28.\|J Integr Neurosci. 2023 May 16, 22(3), 76.\|Patent. US20210378961A1.\|Research Square Preprint. 2024 Apr 23.
Smiles	O=C(C(C=C(OC)C(OC)=C1)=C1C2)C2CC(CC3)CCN3CC4=CC=CC=C4
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	E2020 (free base)
Versandbedingung	Raumtemperatur
Lieferbar
Manufacturer - Type	Reference compound
Manufacturer - Applications	Neuroscience-Neuromodulation
Manufacturer - Targets	Cholinesterase (ChE)
Shipping Temperature	Room Temperature
Storage Conditions	4°C (Powder, sealed storage, away from moisture and light)
Molecular Weight	379.49
Product Description	Donepezil (E2020 free base) is a specific and potent AChE inhibitor with IC50s of 8.12 nM and 11.6 nM for bovine AChE and human AChE, respectively[1].
Manufacturer - Research Area	Neurological Disease; Cancer
Solubility	DMSO: 33.33 mg/mL (ultrasonic)
Manufacturer - Pathway	Neuronal Signaling
Isoform	AChE
Clinical information	Launched

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

HY-14566-10mg-safety-datasheet.pdf